Is Xtant Medical Holdings, Inc. technically bullish or bearish?
2025-09-20 19:58:13As of 12 September 2025, the technical trend for Xtant Medical Holdings, Inc. has changed from sideways to mildly bullish. The daily moving averages indicate a bullish stance, while the weekly MACD and KST are mildly bearish, suggesting mixed signals across different time frames. The Bollinger Bands show a bullish trend on the weekly but a mildly bearish trend on the monthly. Overall, the current technical stance is mildly bullish, driven primarily by the daily moving averages and the monthly MACD. In terms of performance, the stock has outperformed the S&P 500 year-to-date with a return of 48.98% compared to the S&P 500's 12.22%. However, over longer periods, such as 3 years and 5 years, the stock has underperformed significantly against the benchmark....
Read MoreIs Xtant Medical Holdings, Inc. overvalued or undervalued?
2025-09-20 18:31:50As of 15 May 2024, the valuation grade for Xtant Medical Holdings, Inc. has moved from fair to risky, indicating a deterioration in its investment appeal. The company appears to be overvalued given its negative performance metrics, including a Price to Book Value of 2.21 and an EV to Sales ratio of 1.03, which suggest that investors are paying a premium despite the company’s losses. Additionally, the ROE stands at -27.33%, highlighting significant inefficiencies in generating returns for shareholders. In comparison to its peers, Xtant Medical's EV to EBITDA ratio of -38.64 is notably worse than Bioventus, Inc., which has a more favorable EV to EBITDA of 9.72, and Axogen, Inc., which shows a significantly negative P/E of -146.35. The stock has outperformed the S&P 500 with a year-to-date return of 48.98% compared to the index's 12.22%, but this short-term performance does not mitigate the overall valuation ...
Read More





